A detailed history of Schonfeld Strategic Advisors LLC transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 52,100 shares of RGC stock, worth $700,224. This represents 0.01% of its overall portfolio holdings.

Number of Shares
52,100
Holding current value
$700,224
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$15.66 - $877.0 $815,886 - $45.7 Million
52,100 New
52,100 $887,000
Q4 2021

Feb 14, 2022

SELL
$13.43 - $32.87 $136,986 - $335,274
-10,200 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$6.3 - $46.33 $64,260 - $472,566
10,200 New
10,200 $231,000

Others Institutions Holding RGC

About Regencell Bioscience Holdings Ltd


  • Ticker RGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,012,900
  • Market Cap $175M
  • Description
  • Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...
More about RGC
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.